Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Neurotox Res. 2020 Jun 22;38(3):596–602. doi: 10.1007/s12640-020-00238-5

Fig. 3.

Fig. 3.

Effect of various concentrations of beta-hydroxy butyrate (BHB), a FA3R antagonist, on protective effects of butyrate (BUT) against salsilinol (SALS)-induced toxicity. Cells were treated with SALS, BUT and BHB for 24 h and cell viability was determined by MTT. BHB was added 1 h before BUT, which was added 1 h before SALS. Values are mean ± SEM. **p<0.01 compared to control. ††p<0.01 compared to SALS, #p<0.05, ##p<0.01 compared to BUT + SALS. N = 4–5 per treatment